43.20p-1.50 (-3.36%)21 Jun 2021, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Futura Medical PLC Fundamentals

Company NameFutura Medical PLCLast Updated2021-06-21
IndustryBiotechnologySectorHealthcare
Shares in Issue287.071 mMarket Cap£124.01 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.8981Cash Equity Ratio1.1934
Quick Ratio1.3498Current Ratio2.06
Price To Book Value144.9275ROCE0

Futura Medical PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Futura Medical PLC Company Financials

Assets202020192018
Tangible Assets£42,868.00£59,505.00£47,473.00
Intangible Assets000
Investments000
Total Fixed Assets£42,869.00£59,505.00£47,473.00
Stocks0£7,780.00£7,780.00
Debtors£16,067.00£59,968.00£248,426.00
Cash & Equivalents£1.02 m£2.51 m£9.16 m
Other Assets000
Total Assets£1.62 m£4.90 m£10.88 m
Liabilities202020192018
Creditors within 1 year£766,525.00£4.85 m£2.03 m
Creditors after 1 year000
Other Liabilities000
Total Liabilities£766,525.00£4.85 m£2.03 m
Net assets£853,540.00£53,652.00£8.85 m
Equity202020192018
Called up share capital£491,254.00£409,321.00£409,167.00
Share Premium£52.81 m£50.00 m£49.98 m
Profit / Loss-£2.93 m-£11.14 m-£7.24 m
Other Equity£853,540.00£53,652.00£8.85 m
Preference & Minorities000
Total Capital Employed£853,540.00£53,652.00£8.85 m
Ratios202020192018
Debt Ratio000
Debt-to-Equity000
Assets / Equity1.89811.89811.8981
Cash / Equity1.19341.19341.1934
EPS-£0.01-£0.04-£0.04
Cash Flow202020192018
Cash from operating activities-£4.54 m-£6.66 m-£4.71 m
Cashflow before financing-£1.48 m-£6.64 m£772,204.00
Increase in Cash-£1.49 m-£6.65 m£795,270.00
Income202020192018
Turnover0£31,778.000
Cost of sales000
Gross Profit000
Operating Profit-£2.93 m-£11.16 m-£7.27 m
Pre-Tax profit-£2.93 m-£11.14 m-£7.24 m

Futura Medical PLC Company Background

SectorHealthcare
ActivitiesFutura Medical PLC is a drug manufacturer based in the United Kingdom. It lays primary focus exclusively on topically applied pharmaceutical drugs and medical devices which are developed using a highly efficient and proprietary transdermaldelivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. Futura's products are used mainly for the treatment of erectile dysfunction and pain relief.
Latest Interim Date16 Sep 2020
Latest Fiscal Year End Date14 Apr 2021

Futura Medical PLC Directors

AppointedNamePosition
2021-04-20Mr. John Milne ClarkeNon-Executive Director,Chairman
2016-03-31Ms. Lisa Arnold Non-Executive Director
2012-02-01Dr. William Duncan PotterExecutive Director,Chairman
2021-06-03Mr. James Henry BarderExecutive Director,Chief Executive
2021-04-20Mr. Jonathan David Freeman Non-Executive Director
2015-03-28Mr. David Bryn DaviesExecutive Director,Chief Development Officer
2018-04-09Mr. Derek Adrian MartinExecutive Director,Finance Director and Company Secretary
2011-08-09Mr. Anthony Louis Clayden BSc,FCA,MSIExecutive Director,Finance Director and Company Secretary
2021-06-03Mr. Kenneth William JamesExecutive Director,Head of RandD
2021-06-03Ms. Angela HildrethExecutive Director,Finance Director and Chief Operating Officer

Futura Medical PLC Contact Details

Company NameFutura Medical PLC
Address40 Occam Road, Surrey Technology Centre, Guildford, GU2 7YG
Telephone+44 1483685670
Websitehttp://www.futuramedical.com

Futura Medical PLC Advisors

AuditorKPMG
Phone+44 1189642000
Fax+44 1189642222
BankHSBC Bank PLC
SolicitorWithers & Rogers LLP
Phone+44 2079403600
Fax+44 2073789680
StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
Nominated AdviserN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserBuchanan
Phone+44 2074665000
Fax+44 2074665001
SolicitorMemery Crystal
Phone+44 2072425905
Fax+44 2072422058